In the early hours of Friday morning, the Senate passed a $1.3 trillion federal spending bill funding the government until September. It includes new opioid funding and a path for research into the public health aspects of gun violence.
In the early hours of Friday morning, the Senate passed a $1.3 trillion federal spending bill funding the government until September. Early Friday afternoon, President Donald Trump signed the bill after threatening in morning tweets that he would veto it.
The House approved the bill on Thursday.
While some expected Senator Rand Paul, R-Kentucky, to create a repeat of last month's brief shutdown, as he decried the spending in the bill, as well as the process, The Washington Post reported he eventually gave in to the pleadings of Senate Majority Leader Mitch McConnell, R-Kentucky. On Thursday, Paul tweeted about the bill throughout the day, posting a picture of himself holding all 2232 pages of the bill after he printed it out in his office.
The bill would boost investment in the National Institutes of Health (NIH) by $3 billion and includes $3.6 billion in opioid funding, according to Senator Lamar Alexander, R-Tennessee, who chairs the Senate Health Committee. His office said that is an increase of $2.55 billion, or 244%, although drug policy experts have said spending on the magnitude of much more is needed to fight the crisis.
The opioid funding includes:
The funding bill also reopens the path for public health research into gun violence. Such research by the CDC had been banned under the 1996 legislation known as the “Dickey Amendment,” but the new provision partially alters that ban. The Dickey Amendment was supposed to prevent the CDC from advocating for gun control, but it had been interpreted as a blanket prohibition on gun violence research. The new provision will allow CDC to conduct research on the public health impact of gun use, but still prohibits the agency from advocating for gun control.
However, there were also some health measures left out of the bill:
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More